Zydus Wellness Ltd
NSE:ZYDUSWELL
Intrinsic Value
Zydus Wellness Ltd. engages in the business of development, production, marketing, and distribution of health and wellness products. [ Read More ]
The intrinsic value of one
ZYDUSWELL
stock under the Base Case scenario is
1 176.44
INR.
Compared to the current market price of 1 669.45 INR,
Zydus Wellness Ltd
is
Overvalued by 30%.
ZYDUSWELL's market price has consistently been higher than its intrinsic value.This persistent overvaluation suggests the market may be overly optimistic about
ZYDUSWELL or that its price is influenced by factors unrelated to fundamentals.
Zydus Wellness Ltd's market capitalization is 106.2B INR.
ZYDUSWELL stock price is 1 669.45 INR.
ZYDUSWELL stock (1 176.44 INR) is 30% less than its price (1669.45 INR).
ZYDUSWELL stock (836.56 INR) is 50% less than its price (1669.45 INR). Open DCF Valuation
ZYDUSWELL stock (1 516.33 INR) is 9% less than its price (1669.45 INR). Open Relative Valuation
ZYDUSWELL has upside potential of 6% compared to the average analyst price target.
Open Wall St Estimates
ZYDUSWELL's Revenue has grown by 4% over the past 12 months.
ZYDUSWELL's ROIC (Return on Invested Capital) has decreased in the last 3 years from 7% to 6%.
ZYDUSWELL has positive Net Income for the last twelve months.
ZYDUSWELL's ROE (Return on Equity) has increased in the last 3 years from 3% to 5%.
ZYDUSWELL's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 6%.
ZYDUSWELL's ROE (Return on Equity) for the past 12 months is positive and is equal to 5%.
ZYDUSWELL has positive Operating Income for the last twelve months.
ZYDUSWELL's Revenue is forecast to grow at a rate of 9% per year over the next 3 years.
ZYDUSWELL has positive three-year average ROIC (Return on Invested Capital): 7%. The company is efficient at using invested capital to generate operating income.
ZYDUSWELL's Revenue has been growing by 9% per year for the last 3 years.
ZYDUSWELL's short-term assets (9B INR) exceed its short-term liabilties (6B INR).
ZYDUSWELL has positive three-year average ROE (Return on Equity): 5%. The company is efficient at transforming stockholders' equity into net income.
ZYDUSWELL has positive Free Cash Flow for the last twelve months.
ZYDUSWELL has positive Gross Profit for the last twelve months.
ZYDUSWELL's D/E (Debt to Equity) is very low and is equal to 0.
ZYDUSWELL's long-term assets (58B INR) exceed its long-term liabilties (6B INR).
ZYDUSWELL has negative Net Debt. This means that the company has more cash and short-term investments (3B INR) than debt (27m INR).
ZYDUSWELL earns more than enough operating income (3B INR) to safely cover interest payments on its debt (158m INR).
ZYDUSWELL's Altman Z-Score is very high and is equal to 12.06.
Valuation Backtest
Zydus Wellness Ltd
Run backtest to discover the historical profit from buying and selling
ZYDUSWELL
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Zydus Wellness Ltd
Balance Sheet Decomposition
Zydus Wellness Ltd
| Current Assets | 8.9B |
| Cash & Short-Term Investments | 2.5B |
| Receivables | 1.3B |
| Other Current Assets | 5.1B |
| Non-Current Assets | 49.4B |
| Long-Term Investments | 44m |
| PP&E | 2.9B |
| Intangibles | 44.6B |
| Other Non-Current Assets | 1.9B |
| Current Liabilities | 6.1B |
| Accounts Payable | 2B |
| Other Current Liabilities | 4.1B |
| Non-Current Liabilities | 183m |
| Long-Term Debt | 27m |
| Other Non-Current Liabilities | 156m |
Earnings Waterfall
Zydus Wellness Ltd
|
Revenue
|
22.6B
INR
|
|
Cost of Revenue
|
-11.3B
INR
|
|
Gross Profit
|
11.2B
INR
|
|
Operating Expenses
|
-8.6B
INR
|
|
Operating Income
|
2.7B
INR
|
|
Other Expenses
|
-38.8m
INR
|
|
Net Income
|
2.6B
INR
|
Free Cash Flow Analysis
Zydus Wellness Ltd
ZYDUSWELL Profitability Score
Profitability Due Diligence
Zydus Wellness Ltd's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
Score
Zydus Wellness Ltd's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
ZYDUSWELL Solvency Score
Solvency Due Diligence
Zydus Wellness Ltd's solvency score is 90/100. The higher the solvency score, the more solvent the company is.
Score
Zydus Wellness Ltd's solvency score is 90/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ZYDUSWELL Price Targets Summary
Zydus Wellness Ltd
According to Wall Street analysts, the average 1-year price target for
ZYDUSWELL
is 1 764.43 INR
with a low forecast of 1 546.31 INR and a high forecast of 2 005.5 INR.
Shareholder Return
ZYDUSWELL Price
Zydus Wellness Ltd
| Average Annual Return | 6.67% |
| Standard Deviation of Annual Returns | 26.36% |
| Max Drawdown | -42% |
| Market Capitalization | 106.2B INR |
| Shares Outstanding | 63 632 100 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Zydus Wellness Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Zydus Wellness Ltd. engages in the business of development, production, marketing, and distribution of health and wellness products. The company is headquartered in Ahmedabad, Gujarat and currently employs 1,075 full-time employees. The firm operates as an integrated consumer company with business encompassing the entire value chain in the development, production, marketing and distribution of health and wellness products. The product portfolio of the Company includes brands, such as Everyuth, Nutralite, Complan, Glucon-D, Sugarlite, Everyuth, Nycil and Sugar Free D’lite. Complan is a health food drink, scientifically designed for growing school children and contains nutrients along with milk protein. Sugar Free is a low-calorie sweetener, which is a replacement of sugar for the calorie-conscious, weight watchers and diabetics. Glucon-D is a glucose powder, which is available in various flavors variants with Vitamin D and Vitamin C. Everyuth offers a range of skincare products under the brand name of Everyuth Naturals. Nycil prickly heat and cooling powder brand and has also expanded portfolio into hand sanitizer category.
Contact
IPO
Employees
Officers
The intrinsic value of one
ZYDUSWELL
stock under the Base Case scenario is
1 176.44
INR.
Compared to the current market price of 1 669.45 INR,
Zydus Wellness Ltd
is
Overvalued by 30%.
You don't have any saved screeners yet
